Your browser doesn't support javascript.
loading
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.
Moliner, Rafael; Girych, Mykhailo; Brunello, Cecilia A; Kovaleva, Vera; Biojone, Caroline; Enkavi, Giray; Antenucci, Lina; Kot, Erik F; Goncharuk, Sergey A; Kaurinkoski, Katja; Kuutti, Mirjami; Fred, Senem M; Elsilä, Lauri V; Sakson, Sven; Cannarozzo, Cecilia; Diniz, Cassiano R A F; Seiffert, Nina; Rubiolo, Anna; Haapaniemi, Hele; Meshi, Elsa; Nagaeva, Elina; Öhman, Tiina; Róg, Tomasz; Kankuri, Esko; Vilar, Marçal; Varjosalo, Markku; Korpi, Esa R; Permi, Perttu; Mineev, Konstantin S; Saarma, Mart; Vattulainen, Ilpo; Casarotto, Plinio C; Castrén, Eero.
Afiliación
  • Moliner R; Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Girych M; Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Brunello CA; Department of Physics, Faculty of Science, University of Helsinki, Helsinki, Finland.
  • Kovaleva V; Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Biojone C; Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
  • Enkavi G; Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Antenucci L; Department of Biomedicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
  • Kot EF; Translational Neuropsychiatry Unit, Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
  • Goncharuk SA; Department of Physics, Faculty of Science, University of Helsinki, Helsinki, Finland.
  • Kaurinkoski K; Department of Chemistry, Nanoscience Center, University of Jyväskylä, Jyväskylä, Finland.
  • Kuutti M; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, RAS, Moscow, Russia.
  • Fred SM; Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
  • Elsilä LV; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, RAS, Moscow, Russia.
  • Sakson S; Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
  • Cannarozzo C; Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Diniz CRAF; Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Seiffert N; Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Rubiolo A; Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Haapaniemi H; Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
  • Meshi E; Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Nagaeva E; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Öhman T; Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Róg T; Neuroscience, University of Trieste, Trieste, Italy.
  • Kankuri E; Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Vilar M; Biomedical Sciences, Hellenic University of Thessaloniki, Thessaloniki, Greece.
  • Varjosalo M; Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Korpi ER; Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
  • Permi P; Department of Physics, Faculty of Science, University of Helsinki, Helsinki, Finland.
  • Mineev KS; Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Saarma M; Molecular Basis of Neurodegeneration Unit, Instituto de Biomedicina de Valencia, CSIC, Valencia, Spain.
  • Vattulainen I; Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
  • Casarotto PC; Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Castrén E; Department of Chemistry, Nanoscience Center, University of Jyväskylä, Jyväskylä, Finland.
Nat Neurosci ; 26(6): 1032-1041, 2023 06.
Article en En | MEDLINE | ID: mdl-37280397

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psilocibina / Receptor trkB / Alucinógenos / Dietilamida del Ácido Lisérgico / Antidepresivos Límite: Animals / Female / Humans / Male Idioma: En Revista: Nat Neurosci Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psilocibina / Receptor trkB / Alucinógenos / Dietilamida del Ácido Lisérgico / Antidepresivos Límite: Animals / Female / Humans / Male Idioma: En Revista: Nat Neurosci Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Finlandia